S576-1023 Screening compound: N-(1-acetylpiperidin-4-yl)-1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-3-carboxamide

S576-1023 Screening compound: N-(1-acetylpiperidin-4-yl)-1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-3-carboxamide
S576-1023 Screening compound: N-(1-acetylpiperidin-4-yl)-1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S576-1023
N-(1-acetylpiperidin-4-yl)-1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S576-1023

Molecular Formula

C29H40N6O4 (C29 H40 N6 O4)

Compound Name

N-(1-acetylpiperidin-4-yl)-1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-3-carboxamide

IUPAC name

N-(1-acetylpiperidin-4-yl)-1-(1-benzyl-6-oxo-16-dihydropyridazin-4-yl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-3-carboxamide

SMILES

CC(N(CC1)CCC1N(CCN1CCOCC1)C(C(CC1)CN1C(C=NN1Cc2ccccc2)=CC1=O)=O)=O

InChI

InChI=1S/C29H40N6O4/c1-23(36)32-11-8-26(9-12-32)34(14-13-31-15-17-39-18-16-31)29(38)25-7-10-33(22-25)27-19-28(37)35(30-20-27)21-24-5-3-2-4-6-24/h2-6,19-20,25-26H,7-18,21-22H2,1H3/t25-/m1/s1

InChI Key

KBBMEDQMDXSTFO-RUZDIDTESA-N

MDL Number (MFCD)

MFCD31975008

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

536.67

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.257

Distribution Coefficient, logD

1.188

Water Solubility, LogSw

-1.96

Polar Surface Area

77.042

Acid Dissociation Constant (pKa)

23.37

Base Dissociation Constant (pKb)

6.63

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

58.62

S576-1023 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with S576-1023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S576-1023?
Check Price and Availability of S576-1023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S576-1023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S576-1023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S576-1023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S576-1023 available by request